Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of methylnaltrexone on intragastric pressure, transient lower esophageal sphincter relaxations and reflux in healthy subjects
2016-000532-17Phase 4Completed
- Sponsor
- KU Leuven
- Start
- Feb 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of methylnaltrexone in Impaired gastric accommodation (IGA) and gastroesophageal reflux disease (GERD) (2 arms), sponsored by KU Leuven. Primary endpoints: Effect of methylnaltrexone on intragastric pressure, Effect of methylnaltrexone on transient lower esophageal sphincter relaxations and 1 more. Started Feb 2016; status: completed.
02
Drugs
methylnaltrexone
03
Conditions
Impaired gastric accommodation (IGA)gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on 2016-000532-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-000532-17.